Evidence map›Paper›PMID 31239298›Full record

ArticleRNA (New York, N.Y.)2019

PKR activation by noncanonical ligands: a 5'-triphosphate requirement versus antisense contamination.

Sarah A Safran, Debra M Eckert, Evan A Leslie, Brenda L Bass

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Activation of PKR by a short-hairpin RNA.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
  7. Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sarah A SafranDepartment of Biochemistry, University of Utah, Salt Lake City, Utah 84112, USA.
Debra M EckertDepartment of Biochemistry, University of Utah, Salt Lake City, Utah 84112, USA.
Evan A LeslieDepartment of Biochemistry, University of Utah, Salt Lake City, Utah 84112, USA.
Brenda L BassDepartment of Biochemistry, University of Utah, Salt Lake City, Utah 84112, USA.ORCID 0000-0003-1728-2254
University of Utah · US

Funding

Cellular double-stranded RNA as a signal of stress, immunity, and aging.DP1AG044162 · NIA · UNIVERSITY OF UTAH · PI BASS, BRENDA L. · 2012 to 2015
$3.0M
NIA NIH HHS DP1 AG044162
6 · The paper itself

Abstract

Protein kinase RNA-activated (PKR) is an interferon-inducible kinase that is potently activated by long double-stranded RNA (dsRNA). In a previous study, we found that snoRNAs exhibit increased association with PKR in response to metabolic stress. While it was unclear if snoRNAs also activated PKR in cells, activation in vitro was observed. snoRNAs do not exhibit the double-stranded character typically required for activation of PKR, but some studies suggest such RNAs can activate PKR if triphosphorylated at the 5' terminus, or if they are able to form intermolecular dimers. To interrogate the mechanism of PKR activation by snoRNAs in vitro we focused on SNORD113. Using multiple methods for defining the 5'-phosphorylation state, we find that activation of PKR by SNORD113 does not require a 5'-triphosphate. Gel purification from a native gel followed by analysis using analytical ultracentrifugation showed that dimerization was also not responsible for activation. We isolated distinct conformers of SNORD113 from a native polyacrylamide gel and tracked the activating species to dsRNA formed from antisense RNA synthesized during in vitro transcription with T7 RNA polymerase. Similar studies with additional snoRNAs and small RNAs showed the generality of our results. Our studies suggest that a 5' triphosphate is not an activating ligand for PKR, and emphasize the insidious nature of antisense contamination.

Indexed as

DimerizationDNA-Directed RNA PolymeraseseIF-2 KinaseEnzyme ActivationHumansLigandsPhosphorylationPolyphosphatesProtein BindingRNA, Double-StrandedRNA, Small NucleolarTranscription, GeneticUltracentrifugationViral Proteinsbacteriophage T7 RNA polymeraseDNA-Directed RNA PolymeraseseIF-2 KinaseLigandsPolyphosphatesRNA, Double-StrandedRNA, Small Nucleolartriphosphoric acidViral ProteinsantisensedsRNAPKRsnoRNAss-dsRNAT7 RNA polymerase

Identifiers

PMID31239298
PMCPMC6800522
OpenAlexW2953902633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.